Madeleine R. Heldman

699 total citations
33 papers, 354 citations indexed

About

Madeleine R. Heldman is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Madeleine R. Heldman has authored 33 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 10 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Madeleine R. Heldman's work include Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Madeleine R. Heldman is often cited by papers focused on Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Madeleine R. Heldman collaborates with scholars based in United States and Philippines. Madeleine R. Heldman's co-authors include Michelle A. Herrmann, Jin‐Qiu Chen, Paul K. Goldsmith, Noémi Kedei, Peter M. Blumberg, Ajit P. Limaye, Olivia S. Kates, Josh Levitsky, Michael G. Ison and Joshua A. Hill and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Analytical Biochemistry.

In The Last Decade

Madeleine R. Heldman

27 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Madeleine R. Heldman United States	11	106	87	69	67	37	33	354
Paola Serafini Italy	7	65 0.6×	71 0.8×	41 0.6×	29 0.4×	16 0.4×	12	254
Mehwish Younas France	10	58 0.5×	101 1.2×	132 1.9×	41 0.6×	14 0.4×	15	510
Fung-Wei Chang Taiwan	10	111 1.0×	32 0.4×	27 0.4×	49 0.7×	27 0.7×	34	350
Nirit Keren Israel	6	209 2.0×	56 0.6×	44 0.6×	122 1.8×	121 3.3×	7	348
Othman Alharbi Saudi Arabia	16	150 1.4×	118 1.4×	28 0.4×	170 2.5×	141 3.8×	58	628
Christine Yang United States	11	137 1.3×	97 1.1×	20 0.3×	32 0.5×	69 1.9×	24	435
Keren Cohen‐Hagai Israel	11	157 1.5×	47 0.5×	104 1.5×	26 0.4×	43 1.2×	68	463
Chun‐Yu Lin Taiwan	15	122 1.2×	115 1.3×	69 1.0×	53 0.8×	94 2.5×	44	639
Chang Youl Lee South Korea	14	111 1.0×	68 0.8×	86 1.2×	132 2.0×	94 2.5×	65	658
Kevin Fung United States	10	59 0.6×	61 0.7×	34 0.5×	64 1.0×	67 1.8×	22	250

Countries citing papers authored by Madeleine R. Heldman

Since Specialization

Citations

This map shows the geographic impact of Madeleine R. Heldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madeleine R. Heldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madeleine R. Heldman more than expected).

Fields of papers citing papers by Madeleine R. Heldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madeleine R. Heldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madeleine R. Heldman. The network helps show where Madeleine R. Heldman may publish in the future.

Co-authorship network of co-authors of Madeleine R. Heldman

This figure shows the co-authorship network connecting the top 25 collaborators of Madeleine R. Heldman. A scholar is included among the top collaborators of Madeleine R. Heldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madeleine R. Heldman. Madeleine R. Heldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heldman, Madeleine R., et al.. (2025). Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts. Clinical Infectious Diseases. 81(5). 1008–1014. 1 indexed citations

Heldman, Madeleine R., Michael Boeckh, & Michael G. Ison. (2025). Influenza Antivirals for Prevention and Treatment in Immunocompromised People. The Journal of Infectious Diseases. 232(Supplement_3). S243–S253. 3 indexed citations

Wolfe, Cameron R., Arthur W. Baker, Katherine A. Young, et al.. (2025). Outcomes of lung transplantation from SARS-CoV-2 positive donors during the Omicron wave. JHLT Open. 8. 100249–100249. 1 indexed citations

Ni, Bin, Cameron R. Wolfe, Sana Arif, et al.. (2024). Real-World Experience With Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients. Open Forum Infectious Diseases. 11(7). ofae335–ofae335. 6 indexed citations

Wilson, Eleanor, Carolyn Glass, Julie M. Steinbrink, et al.. (2024). Kaposi Sarcoma Due to Possible Donor-Derived Human Herpesvirus-8 Infection in a Cardiac Transplant Recipient. The Journal of Heart and Lung Transplantation. 43(4). S455–S455. 2 indexed citations

Heldman, Madeleine R., et al.. (2024). A practical guide to real‐world implementation of pre‐emptive therapy for Cytomegalovirus disease prevention in high‐risk seronegative liver transplant recipients with seropositive donors. Transplant Infectious Disease. 26(3). e14229–e14229. 2 indexed citations

Heldman, Madeleine R., Julia A. Messina, Annette J. Schlueter, et al.. (2024). Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus. Clinical Transplantation. 39(1). e70073–e70073.

Mullis, Caroline E., Madeleine R. Heldman, Nathan C. Bahr, et al.. (2024). Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient. Transplant Infectious Disease. 26(3). e14271–e14271.

Heldman, Madeleine R., Jennifer L. Saullo, Julia A. Messina, et al.. (2024). Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept. Transplant Infectious Disease. 27(1). e14403–e14403. 2 indexed citations

10.

Heldman, Madeleine R., Jennifer L. Saullo, Julia A. Messina, et al.. (2024). Infections After Belatacept in Lung Transplant Recipients. The Journal of Heart and Lung Transplantation. 43(4). S455–S456.

11.

Heldman, Madeleine R., Nina Singh, Marilyn M. Wagener, et al.. (2023). Real‐world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high‐risk donor seropositive/recipient seronegative (D+R‐) liver transplant recipients (LTxR). Transplant Infectious Disease. 25(2). e14015–e14015. 9 indexed citations

12.

Heldman, Madeleine R., Asim A. Ahmed, Terry Stevens‐Ayers, et al.. (2023). Serial Quantitation of Plasma Microbial Cell-Free DNA Before and After Diagnosis of Pulmonary Invasive Mold Infections After Hematopoietic Cell Transplant. The Journal of Infectious Diseases. 229(2). 576–587. 21 indexed citations

13.

Heldman, Madeleine R., Samuel A. Isaacson, Jingwei Ma, & Konstantinos Spiliopoulos. (2023). Fluctuation analysis for particle-based stochastic reaction–diffusion models. Stochastic Processes and their Applications. 167. 104234–104234.

14.

Heldman, Madeleine R., et al.. (2023). Updates in Cytomegalovirus Prevention and Treatment in Solid Organ Transplantation. Infectious Disease Clinics of North America. 37(3). e1–e16. 3 indexed citations

15.

Heldman, Madeleine R., Jordan Gauthier, Andrew J. Cowan, et al.. (2021). CMV and HSV Pneumonia After Immunosuppressive Agents for Treatment of Cytokine Release Syndrome Due to Chimeric Antigen Receptor–modified T (CAR-T)-Cell Immunotherapy. Journal of Immunotherapy. 44(9). 351–354. 13 indexed citations

16.

Heldman, Madeleine R., Joyce Maalouf, Jessica Morris, et al.. (2021). Association of Inherited Chromosomally Integrated Human Herpesvirus 6 with Neurologic Symptoms and Management after Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 27(9). 795.e1–795.e8. 7 indexed citations

17.

Heldman, Madeleine R. & Olivia S. Kates. (2021). COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature. Current treatment options in infectious diseases. 13(3). 67–82. 16 indexed citations

18.

Chen, Jin‐Qiu, Jih‐Hsiang Lee, Michelle A. Herrmann, et al.. (2013). Capillary Isoelectric-Focusing Immunoassays to Study Dynamic Oncoprotein Phosphorylation and Drug Response to Targeted Therapies in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 12(11). 2601–2613. 24 indexed citations

19.

Kedei, Noémi, Nancy E. Lewin, Tamás Géczy, et al.. (2013). Biological Profile of the Less Lipophilic and Synthetically More Accessible Bryostatin 7 Closely Resembles That of Bryostatin 1. ACS Chemical Biology. 8(4). 767–777. 24 indexed citations

20.

Kohn, Ethan A., Yu-an Yang, Zhijun Du, et al.. (2012). Biological Responses to TGF-β in the Mammary Epithelium Show a Complex Dependency on Smad3 Gene Dosage with Important Implications for Tumor Progression. Molecular Cancer Research. 10(10). 1389–1399. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact